Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 562580, 10 pages
http://dx.doi.org/10.1155/2015/562580
Clinical Study

High Serum Level of β2-Microglobulin in Late Posttransplant Period Predicts Subsequent Decline in Kidney Allograft Function: A Preliminary Study

1Department of Laboratory Diagnostics and General Pathology, State Institution “Zaporizhzhia Medical Academy of Postgraduate Education Ministry of Health of Ukraine”, 20 Winter Boulevard, Zaporizhzhia 69096, Ukraine
2Department of Transplantology, Endocrine Surgery and Cardiovascular Surgery, State Institution “Zaporizhzhia Medical Academy of Postgraduate Education Ministry of Health of Ukraine”, Zaporizhzhia Regional Hospital, 10 Orikhiv Highway, Zaporizhzhia 69050, Ukraine

Received 6 August 2015; Revised 15 October 2015; Accepted 20 October 2015

Academic Editor: Mariann Harangi

Copyright © 2015 Andriy V. Trailin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Saran, Y. Li, B. Robinson et al., “US Renal Data System 2014 annual data report: epidemiology of kidney disease in the United States,” American Journal of Kidney Diseases, vol. 66, no. 1, supplement 1, pp. S1–S306, 2014. View at Google Scholar
  2. J. M. Morales, R. Marcén, D. del Castillo et al., “Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study,” Nephrology Dialysis Transplantation, vol. 27, no. 4, pp. iv39–iv46, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. W. D. Park, T. S. Larson, M. D. Griffin, and M. D. Stegall, “Identification and characterization of kidney transplants with good glomerular filtration rate at one year but subsequent progressive loss of renal function,” Transplantation, vol. 94, no. 9, pp. 931–939, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. W. D. Park, M. D. Griffin, L. D. Cornell, F. G. Cosio, and M. D. Stegall, “Fibrosis with inflammation at one year predicts transplant functional decline,” Journal of the American Society of Nephrology, vol. 21, no. 11, pp. 1987–1997, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Issa, F. G. Cosio, J. M. Gloor et al., “Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels,” Transplantation, vol. 86, no. 5, pp. 681–685, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. M. El-Zoghby, M. D. Stegall, D. J. Lager et al., “Identifying specific causes of kidney allograft loss,” American Journal of Transplantation, vol. 9, no. 3, pp. 527–535, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. B. L. Kasiske, A. K. Israni, J. J. Snyder, and M. A. Skeans, “The relationship between kidney function and long-term graft survival after kidney transplant,” American Journal of Kidney Diseases, vol. 57, no. 3, pp. 466–475, 2011. View at Publisher · View at Google Scholar
  8. M. Magott-Procelewska, M. Boratynska, D. Janczak et al., “Estimated glomerular filtration rate evolution between 6 and 24 months predicts long-term kidney transplant survival among patients with inferior graft function,” Transplantation Proceedings, vol. 41, no. 8, pp. 3028–3032, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Wu, H. Li, H. Huang et al., “Slope of changes in renal function in the first year post-transplantation and one-yr estimated glomerular filtration rate together predict long-term renal allograft survival,” Clinical Transplantation, vol. 24, no. 6, pp. 862–868, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Hariharan, M. A. McBride, W. S. Cherikh, C. B. Tolleris, B. A. Bresnahan, and C. P. Johnson, “Post-transplant renal function in the first year predicts long-term kidney transplant survival,” Kidney International, vol. 62, no. 1, pp. 311–318, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Pascual, M. J. Pérez-Sáez, M. Mir, and M. Crespo, “Chronic renal allograft injury: early detection, accurate diagnosis and management,” Transplantation Reviews, vol. 26, no. 4, pp. 280–290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. KDIGO, “KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease,” Kidney International Supplements, vol. 3, no. 1, pp. 1–150, 2013. View at Google Scholar
  13. M. D. Stegall, R. S. Gaston, F. G. Cosio, and A. Matas, “Through a glass darkly: seeking clarity in preventing late kidney transplant failure,” Journal of the American Society of Nephrology, vol. 26, no. 1, pp. 20–29, 2015. View at Publisher · View at Google Scholar
  14. M. Gera, J. M. Slezak, A. D. Rule, T. S. Larson, M. D. Stegall, and F. G. Cosio, “Assessment of changes in kidney allograft function using creatinine-based estimates of glomerular filtration rate,” American Journal of Transplantation, vol. 7, no. 4, pp. 880–887, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. D. Herrero-Morín, S. Málaga, N. Fernández et al., “Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children,” Critical Care, vol. 11, no. 3, article R59, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Donadio, “Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary β-trace protein,” The American Journal of Physiology—Renal Physiology, vol. 299, no. 6, pp. F1407–F1423, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Bianchi, C. Donadio, G. Tramonti, C. Consani, P. Lorusso, and G. Rossi, “Reappraisal of serum β2-microglobulin as marker of GFR,” Renal Failure, vol. 23, no. 3-4, pp. 419–429, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Donadio, A. Lucchesi, M. Ardini, and R. Giordani, “Cystatin C, β2-microglobulin, and retinol-binding protein as indicators of glomerular filtration rate: comparison with plasma creatinine,” Journal of Pharmaceutical and Biomedical Analysis, vol. 24, no. 5-6, pp. 835–842, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Jovanović, P. Krstivojević, I. Obradović, V. Durdević, and L. Dukanović, “Serum cystatin C and β2-microglobulin as markers of glomerular filtration rate,” Renal Failure, vol. 25, no. 1, pp. 123–133, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. R. P. Woitas, B. Stoffel-Wagner, U. Poege, P. Schiedermaier, U. Spengler, and T. Sauerbruch, “Low-molecular weight proteins as markers for glomerular filtration rate,” Clinical Chemistry, vol. 47, no. 12, pp. 2179–2180, 2001. View at Google Scholar · View at Scopus
  21. Y. Ikezumi, O. Uemura, T. Nagai et al., “Beta-2 microglobulin-based equation for estimating glomerular filtration rates in Japanese children and adolescents,” Clinical and Experimental Nephrology, vol. 19, no. 3, pp. 450–457, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Pertovaara and M. Korpela, “ESSPRI and other patient-reported indices in patients with primary Sjögren's syndrome during 100 consecutive outpatient visits at one rheumatological clinic,” Rheumatology, vol. 53, no. 5, Article ID ket476, pp. 927–931, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. A. C. Carvalho Matos, M. S. Durão Jr., and A. Pacheco-Silva, “Serial beta-2 microglobulin measurement as an auxilliary method in the early diagnosis of cytomegalovirus infection in renal transplant patients,” Transplantation Proceedings, vol. 36, no. 4, pp. 894–895, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Bökenkamp, A. Grabensee, B. Stoffel-Wagner et al., “The beta2-microglobulin/cystatin C ratio—a potential marker of post-transplant lymphoproliferative disease,” Clinical Nephrology, vol. 58, no. 6, pp. 417–422, 2002. View at Google Scholar · View at Scopus
  25. T. P. Vassilakopoulos, G. Nadali, M. K. Angelopoulou et al., “The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma,” Haematologica, vol. 87, no. 7, pp. 701–708, 2002. View at Google Scholar
  26. L. Risch, A. Blumberg, and A. R. Huber, “Assessment of renal function in renal transplant patients using cystatin C. A comparison to other renal function markers and estimates,” Renal Failure, vol. 23, no. 3-4, pp. 439–448, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. S. H. Akbas, A. Yavuz, M. Tuncer et al., “Serum cystatin C as an index of renal function in kidney transplant patients,” Transplantation Proceedings, vol. 36, no. 1, pp. 99–101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. G. K. Sonkar, Usha, and R. G. Singh, “A preliminary study on the significant value of beta-2-microglobulin over serum creatinine in renal transplant rejection and renal failure,” Singapore Medical Journal, vol. 49, no. 10, pp. 786–789, 2008. View at Google Scholar · View at Scopus
  29. B. C. Astor, B. Muth, D. B. Kaufman, J. D. Pirsch, R. M. Hofmann, and A. Djamali, “Serum β2-microglobulin at discharge predicts mortality and graft loss following kidney transplantation,” Kidney International, vol. 84, no. 4, pp. 810–817, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Levey, T. Greene, J. Kusek, and G. Beck, “A simplified equation to predict glomerular filtration rate from serum creatinine,” Journal of the American Society of Nephrology, vol. 11, supplement 2, p. 155, 2000. View at Google Scholar
  31. B. C. Astor, T. Shafi, R. C. Hoogeveen et al., “Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population,” American Journal of Kidney Diseases, vol. 59, no. 5, pp. 653–662, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. S. P. Juraschek, J. Coresh, L. A. Inker et al., “Comparison of serum concentrations of beta-trace protein, beta2-microglobulin, cystatin C, and creatinine in the US population,” Clinical Journal of the American Society of Nephrology, vol. 8, no. 4, pp. 584–592, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Woo, M. Floyd, and D. C. Cannon, “Albumin and β2-microglobulin radioimmunoassays applied to monitoring of renal-allograft function and in differentiating glomerular and tubular diseases,” Clinical Chemistry, vol. 27, no. 5, pp. 709–713, 1981. View at Google Scholar · View at Scopus
  34. G. V. C. Freue, M. Sasaki, A. Meredith et al., “Proteomic signatures in plasma during early acute renal allograft rejection,” Molecular & Cellular Proteomics, vol. 9, no. 9, pp. 1954–1967, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. L. Backman, O. Ringden, I. Bjorkhem, and B. Lindback, “Increased serum β2 microglobulin during rejection, cyclosporine-induced nephrotoxicity, and cytomegalovirus infection in renal transplant recipients,” Transplantation, vol. 42, no. 4, pp. 368–371, 1986. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Sijpkens, A. Zwinderman, M. Mallat, H. Boom, H. De Fijter, and L. Paul, “Intercept and slope analysis of risk factors in chronic renal allograft nephropathy,” Graft, vol. 5, no. 2, pp. 108–113, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. J. R. Chapman, “Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations,” Kidney International, vol. 68, supplement 99, pp. S108–S112, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Gourishankar, L. G. Hunsicker, G. S. Jhangri, S. M. Cockfield, and P. F. Halloran, “The stability of the glomerular filtration rate after renal transplantation is improving,” Journal of the American Society of Nephrology, vol. 14, no. 9, pp. 2387–2394, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. J. S. Gill, M. Tonelli, C. H. Mix, and B. J. G. Pereira, “The change in allograft function among long-term kidney transplant recipients,” Journal of the American Society of Nephrology, vol. 14, no. 6, pp. 1636–1642, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Marcén, J. M. Morales, A. Fernández-Rodriguez et al., “Long-term graft function changes in kidney transplant recipients,” Nephrology, Dialysis, Transplantation Plus, vol. 3, supplement 2, pp. ii2–ii8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. P. F. Halloran, D. G. de Freitas, G. Einecke et al., “An integrated view of molecular changes, histopathology and outcomes in kidney transplants,” American Journal of Transplantation, vol. 10, no. 10, pp. 2223–2230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. B. L. Kasiske, R. S. Gaston, S. Gourishankar et al., “Long-term deterioration of kidney allograft function,” American Journal of Transplantation, vol. 5, no. 6, pp. 1405–1414, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. H.-U. Meier-Kriesche, J. D. Schold, and B. Kaplan, “Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?” American Journal of Transplantation, vol. 4, no. 8, pp. 1289–1295, 2004. View at Publisher · View at Google Scholar · View at Scopus